News Archive

Elixirgen Scientific’s new kit, Quick-miniBrain™ uses ES/iPSC differentiation to form miniaturized, 3D human brain tissues for drug discovery and toxicity screening.

To date, more than $139 million has been committed to over 400 research projects in the state through the fund. Earlier this year, TEDCO awarded $1.1 million to four other stem cell projects. All fund-sponsored projects must be conducted in Maryland and involve human stem cells.

Insightin Health, a Gaithersburg data startup that connects health insurers with consumers, has raised $2 million in seed financing. New York-based venture capital firm Health Catalyst Capital Management led the round with participation from several local investors.

TEDCO has awarded an herbal medicine company in Queen Anne’s County the first round of pre-seed funding offered through its recently expanded Rural Business Innovation Initiative. Lisa Ball, CEO of Plum Dragon, received a $25,000 investment to help grow her Chinese herb business.

BondTrue has also been accepted into the TEDCO’s mdPACE program as it works to expedite the FDA approval process.

A pair of Baltimore-based tech leaders are joining the board of directors for TEDCO.

TEDCO, Maryland’s economic engine for technology companies, announced its annual Entrepreneur Expo & Stem Cell Symposium. Steve Case will serve as the event’s keynote speaker.

Baltimore education technology startup Allovue has raised another $2 million, bringing its Series A financing round total to $7 million.

Local startup ClearMask has landed $25,000 in funding as the winner of this year’s cohort prize for Johns Hopkins’ Social Innovation Lab.

Sterling Partners and the State of Maryland’s TEDCO fund raised Series A funding for Cerebro Capital, an online platform that helps companies analyze, manage and source their corporate credit facilities. Terms of the deal were not disclosed.

A Baltimore medical device startup Tuesday became the latest company to join the Maryland Technology Development Corporation (TEDCO) mdPACE program.

TEDCO portfolio company ClearMask, a Baltimore startup, is working toward gaining clearance from the U.S. Food and Drug Administration for its device that could improve in-surgery communication.

Therapeutics Based on Induced Pluripotent Stem Cells Are Nearing Clinical Trials.

The announcement reflects some recent changes to the Maryland agency’s approach to seed investing.